Resistant Starch From High Amylose Maize (Ham-Rs2) And Dietary Butyrate Reduce Abdominal Fat By A Different Apparent Mechanism

Kirk Vidrine,Jianping Ye,Roy J Martin,Kathleen L McCutcheon,Anne M Raggio,Christine Pelkman,Holiday A Durham,June Zhou,Reshani N Senevirathne,Cathy Williams,Frank Greenway,John Finley,Zhanguo Gao,Felicia Goldsmith,Michael J Keenan
DOI: https://doi.org/10.1002/oby.20501
IF: 9.298
2014-01-01
Obesity
Abstract:Objective: Obesity is a health concern. Resistant starch (RS) type 2 from high-amylose maize (HAM-RS2) and dietary sodium butyrate (SB) reduce abdominal fat in rodents. RS treatment is associated with increased gut hormones peptide YY (PYY) and glucagon-like peptide 1 (GLP-1), but it is not known if SB increases these hormones.Design and Methods: This was investigated in a 2 3 2 rat study with HAM-RS2 (0 or 28% weight) and dietary sodium butyrate (0 and 3.2%) resulting in isocaloric treatments: energy control (EC), sodium butyrate (SB), HAM-RS2 (RS), and the combination (SBRS).Results: RS and SB reduced abdominal fat and the combination reduced abdominal fat compared to SB and RS. RS was associated with increased fermentation in the cecum. Serum PYY and GLP-1 total were increased with RS treatment. RS treatment was associated with increased cecal butyrate produced from fermentation of RS, but there was no cecal increase for dietary SB.Conclusions: SB after its absorption into the blood appears to not affect production of PYY and GLP-1, while butyrate from fermentation in the cecum promotes increased PYY and GLP-1. Future studies with lower doses of RS and SB are warranted and the combination may be beneficial for human health.
What problem does this paper attempt to address?